What's breaking now, across thousands of outlets.
(MedPage Today) -- Drugmaker Novartis acknowledged Thursday that there have been nine reports of tumors in children treated with its gene therapy onasemnogene abeparvovec (Zolgensma) for spinal muscular atrophy (SMA). Two of the tumor cases were...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
In this GEN webinar, two experts will show how ultra-sensitive, multiplexed proteomics can measure both the pace of aging and the effects of interventions designed to change it.
Archaeologists who led a dig at a monumental tomb in Siberia said they turned up evidence of the earliest known use of cannabis for psychoactive purposes.
A new drug, Hibsago, can bring the virus to negligible levels for some patients
Ever heard of the winter blues? The phrase describes that blah, low-energy feeling that can settle in as days grow shorter, colder and grayer this time of year.
The Ford government remains under fire after a Toronto woman was denied OHIP funding for out-of-country cancer treatment.
